Rhenman & Partners Asset Management Ab Epizyme, Inc. Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$1.06 - $2.68 $280,900 - $710,200	-265,000 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$13.68 - $20.46 $1.16 Million - $1.74 Million	-85,000 Reduced 24.29%	265,000 $4.26 Million
Q1 2020 Apr 16, 2020	SELL	$14.83 - $26.72 $1.11 Million - $2 Million	-75,000 Reduced 17.65%	350,000 $5.43 Million
Q4 2019 Jan 17, 2020	SELL	$9.77 - $24.6 $244,523 - $615,688	-25,028 Reduced 5.56%	425,000 $10.5 Million
Q3 2019 Oct 16, 2019	SELL	$10.17 - $13.86 $443,930 - $605,002	-43,651 Reduced 8.84%	450,028 $4.64 Million
Q2 2019 Jul 22, 2019	BUY	$11.43 - $15.12 $4.97 Million - $6.57 Million	434,474 Added 733.85%	493,679 $6.2 Million
Q1 2019 Apr 11, 2019	BUY	$5.98 - $13.98 $354,045 - $827,685	59,205 New	59,205 $734,000
Q2 2018 Jul 20, 2018	SELL	$12.85 - $18.45 $2.33 Million - $3.34 Million	-181,291 Closed	0 $0
Q1 2018 Apr 11, 2018	SELL	$12.5 - $19.75 $453,750 - $716,925	-36,300 Reduced 16.68%	181,291 $3.22 Million
Q4 2017 Jan 19, 2018	SELL	$11.55 - $20.1 $216,008 - $375,910	-18,702 Reduced 7.91%	217,591 $2.73 Million
Q3 2017 Oct 13, 2017	BUY	$12.7 - $19.25 $3 Million - $4.55 Million	236,293	236,293 $4.5 Million

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.